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Abstract  
Diabetes distress (DD) represents a significant clinical burden in which levels of DD are related to 
both HbA1c and some self-management behaviours. DD is related to, but different from, depression. 
Differences in DD experienced in people with type 1 and type 2 have been observed. Commonly 
measured by the Problem Areas in Diabetes Scale and the Diabetes Distress Scale, rates of elevated 
DD in research study participants range 20-30%. Risk factors for elevated DD in type 1 are a longer 
duration of diabetes, severe hypoglycaemia, younger age and being female.  A systematic review of 
intervention studies assessing DD identified eight RCTs and nine pre-post design studies. Only three 
studies targeted DD with the intervention. Intervention types were diabetes self-management 
education (DSME); psychologically informed self-management and; devices. DSME pre-post studies, 
namely the DAFNE programme (Dose Adjustment For Normal Eating), produced more consistent 
improvements in DD and HbA1c at follow up. Psychologically informed self-management were more 
heterogeneous but several RCTs were effective in reducing DD. Group interventions offered the 
greatest benefits across intervention designs. 
 
 
Introduction 
Diabetes Distress (DD) has been increasingly recognised in research practice for two decades but has 
only recently achieved a sharper focus in clinical practice. Much of the research attention has been 
in type 2 diabetes. This paper is the first to review the evidence for DD in type 1 diabetes. We 
present a definition of DD and consider it's associations with the important diabetes end points of 
glycaemic control, self-management behaviours and depression. Rates of elevated DD in research 
populations and the relative merits of screening for DD are considered. We present a systematic 
review of interventions for managing DD in clinical environments. The paper concludes with a 
number of research priorities to further our understanding of DD in people with type 1 diabetes. 
 
 
 
 
Definition of Diabetes Distress 
Diabetes distress (DD) reflects a range of different emotional response to patient’s perceptions of 
health threats balanced against an appraisal of available coping resources, and it is content-related 
necessitating a focus on distinguishing among the different sources of distress in diabetes so that 
specific interventions can be initiated (1). Esbitt et al (2) explain that DD is “predicated on a variety 
of medical, contextual and individual factors, not on the presence of a psychiatric condition” (p35).  
 
Manifestation of Diabetes Distress in type 1 and type 2 diabetes 
Some studies suggest that DD does not discriminate by diabetes type (3, 4), but it cannot be 
presumed that emotional problems are similarly experienced, and have the same consequences in 
Type 1 and 2 diabetes. Indeed, the most commonly reported emotional problems in Type 1 diabetes 
relate to hypoglycaemia and complications; worry about the future and complications, feeling burnt 
out/overwhelmed, and worrying about low blood sugar reactions (5-7), whereas in Type 2 diabetes 
emotional distress relates more to goal setting and food restrictions (7). Qualitative work confirms 
stressors unique to Type 1 diabetes; realisation of  the possible consequences of previously poor 
self-management as adolescents, apprehension about pregnancy, anxiety about being perceived to 
have Type 2 diabetes, frustration competing for resources with Type 2 diabetes and a great many 
concerns specific to insulin use (8, 9). Our own case note documentary  analysis observed 
differences in the manifestation of DD in the two populations (10). Type 1 case notes revealed core 
issues resulting in elevated DD being lack of diabetes control and fear of associated complications 
with common behavioural manifestations resulting in the maintenance of high blood glucose levels; 
low levels of blood glucose monitoring and medication non-concordance. In contrast, type 2 case 
notes indicated; Isolation, work related issues, family demands, obesity and lack of knowledge. We 
found some diabetes distress themes reported in both  type 1 and 2;  neuropathic pain, fear of 
complications, fear of hypoglycaemia, poor sleep, loss of medication or diet control, dietary control 
(calorie restriction in type 2 and carbohydrate  counting in type 1), loss of independence and lack of 
support. It is clear from this early understanding of differences in DD that different management foci 
may be required.   
 
Diabetes Distress related to depression  
Previous psychological research in diabetes has focussed on depression, but it is now apparent that 
there has been a lack of clarity and precision in the measurement of depression in diabetes (1, 11). 
Depression and DD are strongly associated in Type 2 (12) but also in Type 1 diabetes (9, 13). 
Prospective research in mixed diabetes samples suggests a bidirectional association (7, 14, 15), with 
emerging evidence in Type 1 diabetes that DD exacerbates the risk of incident depressive symptoms 
two fold (16). Depression assessment constitutes a symptom count irrespective of cause or context, 
whereas DD reflects an emotional response to the adversity associated with living with and 
managing diabetes (11), and Fisher et al (1) explain that “exclusively symptom based depression 
scores most likely capture the affect component of DD” (p769). Qualitative studies suggest that 
where a person with type 1 diabetes has depression it is often related to their experience of 
diabetes (9, 17). Fisher et al (1) explain that emotional distress in diabetes should be considered “a 
single continuous dimension that has two primary characteristics: content and severity; that the 
primary content of emotional distress among these individuals include diabetes, it’s management, 
other life stresses and other contributors (e.g. personal characteristics, life history and genetics)” 
(p764). There is therefore a need to move beyond conceptualising ‘distress’ in diabetes as 
diagnosable depression and recognise the impact of disease-related factors on emotional well-being 
(18). 
 
Measurement of Diabetes Distress 
The concept of DD emerged alongside the development of the Problem Areas in Diabetes (PAID) 
scale (19), with later revisions resulting in the Diabetes Distress Scale (DDS) (20). We recently 
completed work to  distinguish between measures of DD (unpublished data).  The PAID was 
developed with a sample predominantly comprised of people with Type 1 diabetes (19), and the 
psychometric properties of the DDS for adults with Type 1 diabetes has recently been established 
(21). These measures have been extensively psychometrically evaluated in type 1 and type 2 
diabetes (22), parents (23), adolescents (24) and languages and cultures (21, 25, 26). Qualitative 
work, however, suggests additional aspects of DD important in Type 1 diabetes are omitted from 
these measures; fear of hypoglycaemia, problems maintaining a normal work-life balance, fatigue 
(21), and guilt about social burden, for example the possibility of an emergency (9). As a result of 
these concerns, the Type 1 Diabetes Distress Scale (DDS-T1) was recently developed (27). The DDS 
and DDS-T1 are comprised of empirically established sub-scales such as the DDS emotional burden 
and regimen distress sub-scales (20, 27) and have been employed in research studies (28). Short 
forms and screeners such as the DDS2 and PAID-5 are also available (3, 29-31).   
 
Relationship to endpoints in Type 1 diabetes 
HbA1c 
Cross-sectional evidence has consistently shown that any one point in time someone with elevated 
DD is likely also to have high HbA1c in type 1 diabetes  (5, 32). However, DD is not prospectively 
related to HbA1c when baseline HbA1c is controlled for; someone experiencing higher DD is not 
apparently at risk of increasing their HbA1c, or indeed developing high HbA1c, as a result of this 
initial distress, at follow up. (33) (34) However,  some evidence in type 1 diabetes suggests that  
intervention related changes in DD are associated with changes in HbA1c with a marginally 
significant trend suggesting these concurrent changes are related although causality cannot be 
inferred (35). This mirrors findings in Type 2 diabetes (36). Furthermore, Weinger et al (2001) found 
that high baseline DD hampers improvement in HbA1 suggesting that interventions must address 
existing DD to evidence improvement in clinical outcomes(35). Some unpublished studies have failed 
to support an association between DD and HbA1c in Type 1 diabetes though (37, 38), suggesting a 
complex relationship between these variables that requires further exploration. DD has been shown 
to explain the relationship between depressive symptoms and HbA1c (3, 39). This mirrors evidence 
in mixed and Type 2 diabetes samples (7, 40-42). 
 
Self-management behaviours 
Cross-sectional evidence suggests that DD impacts self-management behaviors in Type 1 diabetes, 
namely less physical activity, poorer diet (21) and eating styles that are associated with overeating 
and high HbA1c (6) and insulin restriction (43, 44) . Other studies suggest DD is not associated with 
self-monitoring of blood glucose, smoking and alcohol consumption, and that its association with 
physical activity may be explained by more general emotional distress (13).This evidence base is very 
much underdeveloped at present, though. Martyn-Nemeth (2014) identified that there may be a 
level at which DD becomes immobilising resulting in fewer behaviours to avoid hypoglycaemia at 
very high levels of DD (6). Sturt et al (2015b) found that in type 1 and 2, people with elevated 
diabetes distress alongside psychological morbidity, including low mood, were unable to convert 
strongly desired self-care intentions into actions (10). Conversely, individuals with diabetes distress 
only were more successful at initiating self-care behaviours’ and developing self-efficacy indicating 
that DD alone is easier to target (10). Other mixed type and type 2 only studies have found that it is 
the co-morbidity of DD and depression that is associated with the highest levels of HbA1c (45-47). 
This suggests that when you have both DD and depression it impacts the most on self-management 
behaviours that aim to control glycaemia and becomes most difficult to resolve.  
 
Regimen distress and diabetes endpoints 
Research in Type 1 diabetes has explicitly demonstrated that the element of DD that appears to 
drive the aforementioned associations with HbA1c, and self-management behaviour, is regimen 
distress (6, 21, 33, 35, 39, 48). The smallest change in regimen distress which can be subjectively 
realised by individuals, 0.5 SD change, is associated with a difference of 7 mmol/mol (0.6%) in HbA1c 
(39). 
 
Thresholds for, and rates of, clinically relevant DD  
No epidemiological studies have assessed for DD therefore all data on degrees of DD amongst 
people with diabetes and proportions of people with diabetes experiencing elevated DD are derived 
from interventional or cross sectional research studies which in itself results in a likely population 
bias. Investigators have used a range of thresholds across type 1 and 2 populations to define 
elevated DD from PAID scores in the low 30s (49, 50) to 45-50 (51, 52). Studies in Type 1 diabetes 
have endeavoured to establish the curvilinear relationship which has been observed in type 2 
between DD and HbA1c, diet and physical activity (53). In Type 2 diabetes the shape of these 
relationships indicated thresholds for low (a DDS mean score of 1-2), moderate (a DDS mean score 
of 2-3) and high (a DDS mean score over 3) clinically relevant DD; each successive increase in DD is 
associated with a 0.5 SD increase in HbAc1 or decrease in self-management behaviour. However, the 
studies in Type 1 diabetes found no evidence of these relationships (21, 39), suggesting that 
emotional problems have different implications in Type 1 and 2 diabetes and that in Type 1 diabetes 
interventions can be applied, and will be effective, at any non-zero level of DD (21).  
The majority of empirical studies to date have used thresholds of PAID ≥40 and a DDS >3 to indicate 
elevated DD (28). In scoping the literature we identified 11 studies which have reported proportions 
of type 1 populations with elevated DD (2, 21, 38, 47, 54-60). These proportions range from 8% (57) 
to 65% (2). Nearly half of these studies (combined population of 875 participants) reported 
proportions of participants with elevated DD of between 17-31% (38, 47, 58, 60, 61). The mean ages 
of participants in these studies was between 37-52 yrs with the largest study reporting on 466 
participants, mean age 37yrs, finding 28% to have elevated DD (47). A large international study with 
8,500 participants (DAWN 2 study), of which 16% were type 1, found 44.6 % of the study population 
to have elevated DD on the PAID 5 (62). The evidence suggest that 20-30% of people with type 1 
diabetes will be experiencing elevated diabetes distress that will be affecting their self-management 
behaviours and their glycaemic control. Given that the majority of the evidence we have observed 
did not have psychological morbidity inclusion criteria and that those with psychological morbidity 
would be regarded as hard to reach and unlikely to volunteer for research participation, it is likely 
that this is an underestimation of the true picture.   
 
Specifically in Type 1 diabetes, risk factors for DD include a longer duration of diabetes (21, 63) and 
episodes of severe hypoglycaemia (5). Age is also negatively correlated with DD (5, 21) with 
adolescents and younger adults endorsing feeling scared when thinking about living with diabetes, 
guilty about getting off track with diabetes management, unsatisfied with their diabetes physician, 
discouraged with their diabetes routine, and experiencing uncomfortable interactions about 
diabetes with family/friends as more serious concerns than do older adults with Type 1 diabetes (5). 
DD is greater for women than men (21, 49, 63, 64) with women also exhibiting higher prevalence of 
subcutaneous insulin infusion, greater self-monitoring of blood glucose and a higher level of 
motivation yet no difference in HbA1c level perhaps suggesting that greater effort in maintaining 
HbA1c is at the cost of higher DD (49). Interestingly women, but not men, with Type 1 diabetes have 
been shown to experience greater DD when they live without a partner, an effect that is partly 
explained by social support albeit the precise mechanisms of this association have yet to be 
established (65). 
 
The pros and cons of screening  
Routine psychosocial screening for DD and depression has been recommended at key time points in 
the care pathway, including; diagnosis, annual reviews, in-patient episodes, new complications, and 
when issues of glycaemic control, self-management and quality of life arise (66). The incorporation of 
psychosocial assessment and treatment into routine care, through a collaborative team approach, is 
recommended (11, 66, 67), however, no screening studies involving only the assessment for DD have 
been conducted solely in type 1 populations. These recommendations assume firstly that the 
screening process is effective in detecting vulnerable people, secondly that psychosocial care 
pathways are routinely available and thirdly that these services are acceptable to patients. Fleer 
(2013) found in a mixed type 1/type 2 sample that only 36 of the 104 participants found to have 
elevated DD accepted further referral to psychological services (57). With limited resources, Byrne et 
al (2012) argue that individuals likely to benefit the most should be targeted for intervention, including 
those with higher diabetes distress at baseline (50). Ironically, the hard to reach group that don’t 
respond to screening, have the most to benefit from it (57). Conflicting evidence exists concerning 
diabetes healthcare professionals capacity to clinically detect diabetes distress. Pouwer et al (2006) 
report under detection of DD by diabetes nurse specialists in 75% of patients with established distress 
(68). Conversely, Sturt et al (2015a) found that clinicians were able to detect elevated DD during their 
routine consultations (10). Clinicians may not seek to uncover DD if local psychological care services 
and care pathways don’t exist for the management of elevated DD. Fleer et al (2013) suggested that 
where integrated systems are not available we shouldn’t be screening (57). Undertaking service audit 
to identify local prevalence of elevated DD may have greater merit enabling business cases to be 
developed for the provision of psychological care pathways in diabetes. 
 
The treatment and management of Diabetes Distress: a systematic review 
Methods  
Given the relative novelty of clinical detection and management of DD in clinical practice outside of 
research studies, we sought to undertake a systematic approach to the identification and appraisal 
of effective treatment and management strategies. We updated a previous review of effective 
interventions for reducing DD in type 1 and type 2 populations (28). We searched Medline, Psychinfo 
and Embase from March 2013 to March 2015, for additional research studies reporting diabetes 
distress outcomes using the full PAID or DDS.  From our previous review (28) 14 type 1 studies, were 
included. Figure 1 illustrates our combined flow diagram of included studies. The updated search 
identified 293 citations and two people assessed each. Mixed diabetes population studies were 
included where the type 1 population data could be reported separately. One further unique 
experimental study was included. Two papers, published post March 2015, were identified through 
personal contacts. Due to heterogeneity in both intervention and research design we undertook a 
narrative synthesis. 
 
Figure 1. Flow diagram of included studies 
 
Managing diabetes distress 
Seventeen studies reporting DD related intervention outcomes specifically for adults with T1DM 
were identified; of these 8 were RCTs, and 9 were pre-post studies. The PAID was used in 15 studies 
and the DDS in 2 studies. These studies are described in Table 1. Reduction of DD was the sole or co-
primary outcome in two studies (56, 69) and a secondary outcome in the remainder. This indicates 
that the majority of studies are not targeting DD but rather determining whether an intervention 
targeting another outcome, worsens or improves DD.  Reduction of DD was reported in all studies, 
however not always significantly. Our synthesis has categorised interventions into three groups: 
Diabetes self-management education (DSME); Self-management with a psychological component 
and; Devices. 
 
Table 1. Characteristics of intervention studies 
Six studies investigated DSME interventions which aimed  to reduce HbA1c by providing knowledge 
about diabetes and the technical skills needed to manage the condition  and may include goal-
setting and problem-solving. All DSME intervention studies but one (50) (who did not report 
significance levels) reported significant reductions in DD (35, 70-73) and in HbA1c when reported 
(35, 71, 72). The DSME Intervention studies were pre-post design and five of the six evaluated the 
DAFNE programme (Dose Adjustment For Normal Eating) and thus are generally more homogeneous 
which may account for the consistent positive impact on DD across these DSME interventions. The 
RCT studies of DAFNE (74) did not report DD as an outcome and so it is not possible to be definitively 
convinced that DSME, and DAFNE in particular, improved DD compared to controls. A study to 
evaluate the impact of the DAFNE program on people with elevated DD would be an important next 
step in the evaluation of both DAFNE and elevated DD.  
Nine studies comprised our second category, self-management interventions with a psychological 
component.  In addition to some degree of self-management education these studies have a 
psychological component focusing on the multidimensional aspects and perceptions of living with 
diabetes. These interventions aim to develop strategies to cope with the emotional stress of 
managing the disease and modify unhelpful cognitions. In addition, knowledge provided by the self-
management components is utilised by focusing on experiential learning that influence behaviours, 
psychological adaptation and glycaemic control (56, 69, 75-81). The results of these were less clear 
regarding significant changes in DD. Four studies showed significant reductions of DD in addition to 
significant reductions in HbA1c (76, 77, 80, 81). Zoffmann et al (2015) showed significant reductions 
of both DD and HbA1c in women but not in men (78). In two pilot studies Snoek et al (2001) showed 
significant reductions in Hba1c and marginally significant reduction in DD (p=0.06) and Esbit et al 
(2014) reported an effect size of 0.34 relating to DD but no effect on Hba1c (69, 79). Likewise, Due-
Christensen (2012) reported an effect size of 0.55 relating to reduction in DD (p ≤ 0.001) but no 
change in HbA1c was seen (56). Interventions were primarily delivered by diabetes educators. 
Psychologists or psychiatrists were part of the intervention in 6 studies (56, 69, 75, 76, 79, 81). The 
psychological intervention components were empowerment and supportive counselling, use of self-
determination approaches, and Cognitive Behaviour Therapy (CBT).  
Two studies tested the efficacy of devices, Continuous Glucose Monitoring (61) and Sensor 
Augmented Pump therapy (82).  Pump-initiation with 3 individual sessions focusing on blood glucose 
control reduced DD as compared to Multiple Daily Injection (MDI) treatment (82). DD was not 
affected negatively by use of CGM with either real time or retrospective bio-feedback (61).  
 
The most common feature of effective interventions across the 17 studies was the group format 
which likely taps into natural social support, social learning theory and social comparison theory 
enabling people to establish a sense of normalcy and acquire positive vicarious learning experiences 
which successfully aid in breaking isolation and feelings of loneliness in living with type 1 diabetes 
(83). Groups aimed to share how participants addressed emotional or cognitive problems in relation 
to performing diabetes specific behaviours and challenges in coping with the demands of diabetes. 
Problem-solving, goal-setting, focus on motivational barriers and facilitators were also utilised. 
Homework sheets were used to develop person specific knowledge of illness perception and to 
enhance reflection on beliefs and attitudes towards diabetes that might need to be changed or 
reinforced. Studies using a group format and goal setting, problem-solving, reflection, written 
homework, motivational focus, supportive listening, cognitive restructuring, and addressing 
emotional challenges seem to offer greater reductions in DD and HbA1c.  
The populations under study were predominantly mid-forties with diabetes duration of more than 
13 years displaying levels of DD ranging from 20 to 44.4 on PAID with the majority scoring > 30. The 
review has identified a lack of interventions targeting elevated DD, aiming at emerging adults and 
also older adults. As it seems DD is present throughout the lifespan it would be important to address 
this during the early years of adulthood and also in the early stages of diabetes to prevent 
longstanding DD. In addition, interventions targeting older adults with DD relating to a more severe 
disease because of complications might be beneficial.  
To summarise, the management of DD in type 1 is in its infancy in relation to both research evidence 
and clinical practice. DSME appears to reduce DD in type 1. Psychologically enhanced self-
management interventions reviewed were more heterogeneous than the DSME, predominantly 
DAFNE, studies that we have reviewed.  Nonetheless, these theory based interventions may have 
the potential to address elevated DD. Group based interventions appear to have merit.  
 
Conclusions 
Summary of evidence 
This comprehensive review of the topic has identified that elevated Diabetes Distress is experienced 
by 20-30% of people with type 1 diabetes, that there are well validated scales for assessing DD and 
whilst many intervention studies have assessed for it, few have targeted elevated DD. There is a 
rising imperative to clinically consider the role of elevated DD when providing routine care for type 1 
populations. There is growing, albeit currently underdeveloped, evidence of a relationship between 
DD, self-management behaviours and glycaemic control. There is enough evidence though to 
warrant the further exploration of the role of elevated DD in influencing HbA1c and self-
management behaviours crucial to good diabetes health such as blood glucose monitoring and 
insulin administration or restriction.  
 
Controversial issues 
Cross-sectional evidence developed in type 2 diabetes is contradictory and ambiguous; investigators 
have found DD to be independently associated with some self-management behaviours and to 
explain some, albeit not all, of the associations of depressive symptoms with these outcomes (42, 
84), others have shown that it is depressive symptoms, not DD, that exhibits an independent 
association with self-management behaviours (40, 85). Whilst prospective research has found self-
management behaviours specifically related to diabetes, and which directly influence HbA1c (i.e. 
medication adherence), are influenced by DD, whereas only depressive symptoms impacts other 
more lifestyle oriented behaviours including those that are recommended in diabetes (40). This 
evidence is not available in type 1. 
 
Recommendations for further research  
As the focus of DD research has shifted to Type 1 diabetes only very recently, many important 
questions remain. Much of the extant research is in younger adults, for example those aged 18-35 
years. Most of the research in Type 1 has been done in Scandinavian countries, namely Norway and 
Denmark potentially limiting the generalisability of the findings. It remains unclear whether diabetes 
specialist clinicians are able to detect DD clinically within their routine consultations and, more so, 
what is the impact on detection rates when a clear care pathway for elevated DD exists? Diabetes 
population screening, using the available validated tools, is not appropriate in the absence of 
effectiveness and cost effectiveness evidence related to caseness. Research in these areas has not 
yet commenced.  
 
People with DD and without co-morbid depression may be more responsive to intervention which 
presents a case for research to detect and manage DD. The prevalence and natural history of DD and 
DD with co-morbid depression is unknown at the diabetes population level. DSME appears to reduce 
DD in type 1 and many national diabetes policies recommend the routine provision of DSME.  People 
experiencing elevated DD are likely to need greater support to achieve DSME participation but the 
benefits to them may well out way the additional resource required to engage them in DSME.  
Research to evaluate the impact of DSME in patients with elevated DD is warranted. Evidence of one 
to one or ehealth/mhealth interventions, and research in older age participants, is lacking.  
 
Work delineating the prospective, time-varying, associations between DD and HbA1c and self-
management behaviours, whilst accounting for depressive symptoms, is required in Type 1 diabetes. 
Should these relationships be confirmed, it is critical to then establish the causal linkages between 
these variables, the pace of the associations, the complex interactive biological, behavioural and 
affective mechanisms/third variables involved, and the contextual and individual difference variable 
that determine these associations and their causal pathways (e.g. stage of disease, age, gender, 
burden of disease, presence of co-morbidities) (86). Once this evidence base has been established, 
there is a need to then develop and test interventions targeting DD, the mechanisms that underpin 
the association of DD and HbA1c, and specific sub-groups at risk of high DD and for whom the 
DD/HbA1c association is particularly strong, in order to maximise outcomes in Type 1 diabetes. Such 
studies should also elicit the mechanisms, mediators and moderators of any improvement in DD and 
other endpoints.  
 
A few of these questions have been explored in type 2 diabetes and there is a need to continue to 
understand the similarities and differences in the causes and consequences of, and treatment 
options for, DD as they relate to type 1 and type 2 populations. 
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Randomised Control Trials 
Zoffman,  
2006, 
Denmark, 
RCT 
(78) 
61, 
I:61 / C:25, 
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N, 
NR, 
PAID 
36yrs, 
I:46 C:50, 
T1: 100%, 
NR 
I:32 (3.4) 
C:40.9 
(4.0) 
I:9.01 
(0.2);  
C:9.05 
(0.2) 
Empowerment theory based, self-determination theory 
(SDT), self-directed written materials encouraging 
reflection, goal and problem solving oriented; 
supportive listening, motivational focus.  Group face-to-
face, by diabetes educator, 7x 2hour sessions over 8 
weeks.  
Waiting list control 
PAID I: 25.6 (2.7); C: 36.7 (4.5), (p<0.05) 
The intervention group did better than controls re: increased autonomy 
support perceived from HCPs, higher frequency of self-monitored blood 
glucoses, increased perceived competence in managing diabetes, reduced 
diabetes distress (total score and generally consistent for sub-scales esp. 
treatment-related social support distress). 
HbA1c reduced (0.41%) between I and C groups showing a modest but 
long-term effect of the intervention. 
Snoek,  
2008, 
Dutch, 
RCT 
(76) 
86, 
I:45 / C:41, 
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diabetes self-management, reframing of negative 
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weekly. 
PAID: I: 43.4 reduced to 38.3; C: 49.0 reduced to 45.4 
(Intervention x time, 6 months p=0.99; 12 months p=0.68) 
Significant effect for HbA1c reduction in subgroup of depressed patients 
with CBT but not the BGAT group. 
HbA1c no significant changes 
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RCT crossover 
(62) 
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50 crossover, 
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30.7 
(18.8) 
 
I:8.1 (1.5) 
 
Glucose Monitoring Device education, single in-patient 
stay averaging 42 hours, individual face-to-face session, 
delivered by a diabetes specialist, Continuous Glucose 
Monitoring with real time access to results. 
Same group  with retrospective analysis of glucose data. 
Order of condition randomized. 
PAID  baseline: 30.7 (18.8), RA: 28.5 (19.2), RTA 29.2 (21.2) (NS) 
No significant reduction in distress from baseline in either group, nor 
between group differences. Continuous Glucose Monitoring was less 
desirable compared to baseline and the real time or retrospective 
analysis of data made no difference to this outcome. 
 
Amsberg, 
2009, 
Sweden, 
RCT 
(77) 
74, 
I:36 / C:38, 
48wks, 
Y, 
HbA1c, 
PAID 
41yrs, 
49, 
T1:100%, 
21.6 (10.8) 
I:31.1 
(20.4)      
C:33.4 
(17.3) 
>7.5 Theory based CBT, basic programme of 8x 2hr weekly 
group sessions, plus 2x maintenance group sessions, 2x 
individual sessions and 5 phone calls Log book for self-
care activities and emotions, homework  to enhance 
reflection upon self-care behaviours, supportive 
counselling delivered by a diabetes specialist nurse and 
psychologist. 
Usual care 
PAID I: 22.92; C 29.8 (p=0.004) 
Significant differences in DD between groups were observed at 24 weeks 
and maintained throughout the study to week 48.  
Change in HbA1c  was significant between groups at 48 weeks I: 7.72; C: 
8.21 (p=0.012)  
Hermanides, 
2011, 
European, 
RCT 
(83) 
83, 
I:22 / C:21, 
26wks, 
Y, 
HbA1c, 
PAID 
I:39yrs 
C:37yrs, 
I:50 C:54, 
T1:100%, 
I: 16.9 (10.7)  
C: 21.0 (9.4) 
I:32.4 
(18.8) 
C:26.5 
(18.4) 
I:8.45 
(0.95) 
C:8.59 
(0.82) 
Sensor augmented insulin pump treatment, 26 weeks. 
1st 13 weeks no specific instructions given; 2nd 13 weeks 
advised to carbohydrate count. 
Control group on multiple daily injections received 
standard care. 1st 13 weeks no specific instructions given; 
2nd 13 weeks advised to carbohydrate count. 
PAID I: 21.0 (19.3) (p=0.03) in favour of Sensor-Augmented Insulin 
Pump Group. Sensor augmented insulin pump therapy was associated 
with an improvement in diabetes related distress.  
HbA1c I: 7.23. (0.65), C: 8.46 (1.04) (p<0.001) 
 
 
 
 
 
Reference, 
Year, 
Country, 
Methodology 
Recruited, 
I/C group size, 
Length of follow-up, 
Intention-to-treat Y/N, 
Primary outcome, 
Diabetes Distress Measure 
Mean Age, 
Male%, 
T1%, 
Diabetes 
duration 
Baseline  
Diabetes 
Distress 
(I/C) 
Baseline  
HbA1c % 
(I/C) 
Intervention regime and model 
Speciality of therapist 
Control Group 
Outcomes  
Hermanns, 
2013, 
German, 
RCT 
(81) 
160, 
I:81 / C:79, 
6m, 
Y, 
HbA1c, 
DDS 
I:45yrs 
C:46yrs, 
I:51 C:62, 
T1:100%, 
I:19.3 (13.4) 
C:19.6 (12.8) 
 
I:1.3 
C:1.2 
I:8.3 (1.1); 
C:8.1 (1.0) 
Empowerment/self-management theory based, 
(PRIMAS), written materials, homework, problem 
solving, goal setting, addressing emotional problems, 
12x 90min group sessions twice weekly over 6 weeks,. 
Family members or other close relations were invited to 
attend one session on social support. Delivered by 
diabetes educators.  
Control: usual DSME programme: written materials, 
health professional delivered, 12x 90min group sessions. 
DDS: I: -0.3 (0.7), C: -0.1 (0.4) (p=0.032) 
The intervention was superior in reducing diabetes distress, HbA1c and 
increasing empowerment, self-efficacy and satisfaction with insulin 
therapy. Both groups improved awareness of hypoglycaemia, diabetes 
knowledge, self-care behaviour and reduced severe hypoglycaemia 
incidents with no significant between group differences. 
HbA1c in I compared to C (-0.4 + 1.0% vs. 0.0 + 0.6%) (p = 0.012)  
 
Hermanns, 
2015, 
German, 
RCT 
(82) 
214, 
I:106 / C:108, 
12m, 
Y, 
Depressive symptoms, 
PAID 
43yrs, 
43, 
T1: I: 59%, 
C:72%, 
14.2 (10.5) 
40.3 (3.4) 8.9 (1.8) Empowerment/self-management theory based CBT, 
Diabetes motivation strengthening (DIAMOS) for 
patients with subclinical depression, 5x 90min group 
sessions plus telephone support. Coping with diabetes 
related challenges, goal setting and problem-solving, 
motivational strategies, self-directed written materials. 
Delivered by diabetes psychologist. 
Control group 5x 90min group education intervention 
delivered by a healthcare professional. 
PAID: I: -13.0 (18.9) (p=0.001); C:-4.2 (16.9) (p=0.022) 
Type 1 specific: more T1 in control group; analysis stratified by diabetes 
type no significant interaction effects observed except diabetes 
acceptance (less impact on diabetes acceptance in T1 than T2).           
DIAMOS efficacious in treating sub-threshold depression and elevated 
Diabetes Distress more effectively than education alone. Additionally it 
prevents deterioration from sub to major depression. 
HbA1c: I:-0.5 (2.0) p=0.018;   C: -0.7 (1.7) p=0.001 
Zoffman, 
2015, 
Denmark, 
RCT 
(79) 
200, 
I:134 / C:66, 
18m, 
Y, 
HbA1c, 
PAID 
26yrs, 
50, 
T1:100%, 
13.7 (6.8), 
I:36.4 
(21.0) 
C:35.2 
(22.7) 
I:9.5 (1.3); 
C:9.7 (1.5) 
Empowerment theory based SDT, self-directed written 
materials encouraging reflection, goal and problem 
solving oriented, supportive listening, motivational 
focus.  7x either 1hr individual sessions or 2.5hr group 
sessions, over max 12 months.  Delivered by diabetes 
nurse specialists. 
Control group received usual care (3-4monthly 
appointment with diabetes specialist).  
PAID: Difference between I & C (p<0.001); I: (Men -2.6; Women -15.3) 
(p= 0.0024) 
The flexible self-guided determination intervention benefitted younger 
adult women by significantly improving glycaemic control and 
decreasing diabetes related distress. No effect was seen among men. 
HbA1c: I: -0.4%, C: -0.1% (p=0.073) 
Pre/Post Intervention Studies 
Weinger, 
2001, 
American, 
Pre/Post 
(36) 
 
55, 
NA, 
8wks, 
N, 
Emotion/Attitude barriers, 
PAID 
NR, 
44, 
T1:100%, 
NR 
PAID 
40.0 (3.4) 
9.0 Medical/education programme, 8 weeks with monthly 
diabetes clinic MDT, weekly phone contact from 
diabetes nurse to optimise glycaemic control in addition 
8 weeks educational programme either BGAT or 
cholesterol education (no information on group or 
individual provided).  
PAID reduced from 40 to 31 (p<0.01) 
Newly learned self-management needs assistance to be incorporated into 
lifestyle. Intervention needs to help identify potential barriers and the 
necessary steps to achieve self-management goals. PAID particularly 
useful as a screening tool for patients attempting to improve glycaemic 
control.HbA1c9.0% to 7.8% (p=0.0001) 
Snoek,  
2001, 
Dutch, 
Pre/Post 
(70) 
24, 
NA 
6m, 
N, 
HbA1c, 
PAID 
35yrs, 
38, 
T1:100%, 
NR 
39.9 
(16.0) 
9.3 (1.2) Theory based CBT, group session, to improve coping 
with diabetes, cognitive restructuring, stress 
management, behavioural strategies, and homework. 
4x1.5hrs sessions weekly, delivered by a diabetes nurse 
specialist and diabetes psychologist. 
PAID reduced 39.9 (16.0) to 31.2 (17.4) (p=0.06) 
CBGT is feasible in a poorly controlled group; Perceived barriers were 
decreased significantly; general wellbeing was maintained. 
HbA1c reduced 9.3%(1.2) to 8.5% (0.91) (p=0.04);  
 
McIntyre, 
2010, 
Australia, 
Pre/Post 
(74) 
145, 
NA, 
12m, 
N, 
HbA1c, 
43yrs, 
66, 
T1:100%, 
16.7  (11.5) 
25.0 (15-
45) 
8.2 (1.2) DAFNE programme, theory based, 5 consecutive whole 
days delivered in groups, to increase diabetes 
knowledge and self-management skills relating to 
insulin dose adjustment according to food intake aiming 
PAID 25 (15-45) reduced to 16.25 (10-30) (p<0.0001) 
Improved glycaemic control; reduced severe hypoglycaemia incidents, 
improved QOL. 
HbA1c reduced 8.2% to 7.8% 
PAID at patient autonomy, delivered by diabetes specialists 
MDT. 
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Country, 
Methodology 
Recruited, 
I/C group size, 
Length of follow-up, 
Intention-to-treat Y/N, 
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Diabetes Distress Measure 
Mean Age, 
Male%, 
T1%, 
Diabetes 
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Baseline  
Diabetes 
Distress 
(I/C) 
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HbA1c % 
(I/C) 
Intervention regime and model 
Speciality of therapist 
Control Group 
Outcomes  
Engle, 
2011, 
Australia, 
Pre/Post 
(71) 
144, 
NA, 
12m, 
N, 
Wellbeing & coping, 
PAID 
45yrs, 
35, 
T1:100%, 
17.7 (12.42) 
 
I:31.94 
(18.27) 
MDI 28.12 
(20.94); 
CSII 28.92 
(17.11) 
NR DAFNE programme (See McIntyre 2010). 
Usual care comparison to two groups, multiple daily 
injections (MDI) and continuous subcutaneous insulin 
infusion (CSII). 
PAID: I -10.37 (14.67) (p<.001); MDI -2.14 (11.38); CSII -3.98 (9.77).     
OzDAFNE provides a powerful mastery experience, positively influences 
subjective wellbeing and diabetes related distress.     
                  
Keen, 
2011, 
UK, 
Pre/Post 
(73) 
124, 
NA, 
12m, 
N, 
HbA1c, 
PAID 
43yrs, 
56, 
T1:100%, 
17.8 (11.0) 
20 (12.5-
33.8) 
8.6% DAFNE programme (See McIntyre 2010) 
 
PAID:  25 (15-45) reduced to 16.25 (10-30), (p<0.0001) 
DAFNE reduced diabetes related distress, improved glycaemic control, 
reduced severe hypoglycaemia, and improved QOL. 
HbA1c: only the group with > 9.6% had significantly lower at 12m 
(p=0.004) 
Byrne, 
2012, 
UK, 
Pre/Post 
(51) 
437, 
NA, 
18m, 
N, 
Predictors of QOL outcomes, 
PAID 
41yrs, 
46, 
T1:100%, 
15.9 (10.8) 
PAID > 
33: 
166/423 
PAID < 
32: 
257/423 
8.3 (1.4) DAFNE programme (See McIntyre 2010)  PAID: 21.5 (17.92) participants with higher HbA1c and anxiety scores at 
baseline exhibited the greatest reduction in PAID score. No between 
group differences on any measures.  
 
Due-
Christensen, 
2012, 
Denmark, 
Pre/Post 
(57) 
54, 
NA, 
12m, 
Y, 
Diabetes related distress, 
PAID 
 
 
44yrs, 
20, 
T1:100%, 
 21 (11.7) 
37.36 
(16.16) 
>40: 29 
8.2 (1.3) Empowerment theory based, 8 x 2hr 15min group 
sessions over 3-4 months, peer directed themes e.g. fear 
of complications, role of the social network, acceptance 
of diabetes. Motivational strategies, homework sheets to 
enhance reflection, goal setting, and problem-solving. 
Delivered by MDT.  
PAID: 37.36 (16.16) reduced to 27.92 (17.88), (p<0.001; Cohen’s D 
0.55) 
Participation in group support lead to reduced diabetes related distress 
in participants with good and poor glycaemic control.  Glycaemic control 
did not improve at any time point. 
  
Hopkins, 
2012, 
UK, 
Pre/Post 
(72) 
639, 
NA, 
12m, 
N, 
Impact in routine practice, 
PAID 
42yrs, 
NR, 
T1:100%, 
18.0 (12.1) 
25.2 
(17.4) 
8.51 
(1.41) 
DAFNE programme (See McIntyre 2010)  PAID: 25.2 (17.4) reduced to 16.7 (14.1), (p<0.001) 
DAFNE reduces diabetes related distress, improves well-being, reduces 
hypoglycaemic rates and restores hypoglycaemia awareness. 
HbA1c fell by 0.27% (p<0.001)  
 
Esbitt, 
2014, 
American, 
Pre/Post 
(80) 
11, 
NA, 
3m, 
N, 
Feasibility of group CBT, 
DDS 
40yrs, 
50, 
T1:100%, 
22.38yrs 
(11.69) 
3.19 
(0.97) 
8.56 
(1.04) 
Theory based CBT, group-based intervention for 
depression and adherence. 10x 60-90min sessions over 
10 weeks: self-management, depression and diabetes 
related distress in an integrative manner including: 
problem solving, goal setting, motivational consultation, 
DDS: Pre 3.19 (0.97), Post 2.82 (0.98) (Cohen's d=0.34)   
Participation in a group CBT was acceptable, associated with reductions 
in diabetes distress and depressive symptoms.  
HbA1c mean pre score 8.56% post score 8.73% (Cohen’s d= -0.08) 
 education, written materials, self-management 
education. Delivered by diabetes psychologist. 
C= Control Group; CBT= Cognitive behavioural therapy; CGM = Continuous Glucose Monitoring; DAFNE=Dose Adjusted for normal eating; DDS= Diabetes Distress Scale; DSME= Diabetes Self-Management Education; I= Intervention 
Group; M= Months; MDT = Multidisciplinary team; NR= Not reported; NA= Not applicable; PAID= Problem Areas in Diabetes Scale; QOL= Quality of Life; T1= Type 1 Diabetes Mellitus; T2 Type 2 Diabetes Mellitus; wks= weeks; yrs= 
years. 
 
Table 1, Characteristics of intervention studies 
